Stoke Therapeutics, Inc. (STOK)

Stoke Therapeutics Stock Forecast

Stock Price Forecast

The 10 analysts that cover Stoke Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $39.2, which forecasts a 16.98% increase in the stock price over the next year. The lowest target is $25 and the highest is $60.

Price Target: $39.2 (+16.98%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$25	$39.2	$39	$60
Change	-25.40%	+16.98%	+16.38%	+79.05%

Analyst Ratings

The average analyst rating for Stoke Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	5	6	7	8	7	7
Buy	2	2	1	1	2	2
Hold	0	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	9	9	10	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sumant Kulkarni Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $36 → $60	Strong Buy	Maintains	$36 → $60	+79.05%	Mar 20, 2026
Thomas Shrader BTIG	BTIG	Strong Buy Reiterates $39	Strong Buy	Reiterates	$39	+16.38%	Mar 19, 2026
Laura Chico Wedbush	Wedbush	Buy Maintains $36 → $38	Buy	Maintains	$36 → $38	+13.40%	Mar 18, 2026
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Maintains $35	Strong Buy	Maintains	$35	+4.45%	Mar 18, 2026
Laura Chico Wedbush	Wedbush	Buy Maintains $36 → $38	Buy	Maintains	$36 → $38	+13.40%	Mar 17, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

34.37M

Decreased by -81.37%

from 184.42M

Revenue Next Year

62.56M

Increased by 82.05%

from 34.37M

EPS This Year

-3.10

from -0.12

EPS Next Year

-2.59

from -3.10

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	12.41M	8.78M	36.56M	184.42M	34.37M	62.56M
Revenue Growth	-	-	-29.22%	316.34%	404.50%	-81.37%	82.05%
EPS	-2.34	-2.60	-2.38	-1.65	-0.12	-3.10	-2.59
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	15	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	73.5M	110.3M
Avg	34.4M	62.6M
Low	11.8M	34.7M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	-60.1%	220.8%
Avg	-81.4%	82.0%
Low	-93.6%	1.0%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	-2.42	-2.14
Avg	-3.10	-2.59
Low	-3.58	-3.35

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.